A new review by Fern Cohen of Reducing Your Cancer Risk: A holistic approach by Carl O Helvie for the Holistic Cancer foundation can be found in the link below. Enjoy it. https://inspo-media.org/2018/03/10/reducing-your-cancer-risk-a-holistic-approach-by-carl-o-helvie-r-n-dr-p-h/
Posts Tagged ‘Cancer’
Blog Post Review of Reducing Your Cancer Risk: A holistic approach.
Saturday, March 10th, 2018Please Help Cancer Foundation.
Monday, November 6th, 2017
If you shop at amazon please consider switching to smile.amazon.com/ch/46-3798550 and Amazon donates to Carl O Helvie Holistic Cancer Foundation. It does not cost you anything and is the same merchandise. Thank you.
Cannabis Extract Expert, Mara Gordon, Speaks on the Holistic Health Show
Sunday, July 16th, 2017Mara Gordon, founder, Chief Process Engineer, specializes in the development of cannabis extract treatment protocols for seriously ill patients in California. She is the co-founder of Aunt Zelda’s, Calla Spring Wellness, and Zelda Therapeutics.
Prior to Aunt Zelda’s, Mara worked as a process engineer, helping Fortune 500 companies create intelligent software by utilizing the Rational Unified Process. This experience has enabled her to take a detailed and scientific approach to medical cannabis.
Recognizing a need for patient-focused software, Gordon created CDRMed, an EMR specially developed for the healthcare community. With CDRMed, physicians and medical health professionals are able to make treatment recommendations based on the latest and highest-quality data. This takes the guesswork out of selecting the correct medicines at the dispensary.
Gordon sits on the boards of Zelda Therapeutics, Daya Foundation, International Cannabis Standards Board (ICSB), and Hmbldt. She has presented at multiple CME-accredited medical conferences, including Patients Out of Time 2014, and at POT 2016, delivered a 3.5 hour course along with Drs Cristina Sanchez, Manuel Guzman, and Joe D. Goldstrich. Gordon has spoken at medical cannabis conferences in Australia, Costa Rica, Chile, Colombia, the Czech Republic, Israel, as well as numerous events throughout the USA and worldwide. These include CannMed held at Harvard Medical School in April 2016, and Medical Marijuana for Professionals 2014 and 2016. Her work is featured in the upcoming documentaries, “Weed the People”, “Mary Janes: Women of Weed”, and in Joe Dolce’s book, “Brave New Weed”.More information at: https://www.medicaljane.com/directory/professional/mara-gordon/
Enjoy the Interview below:
Liquid Biopsy/ Evaluating Cancer Treatment
Wednesday, July 5th, 2017Liquid Biopsy, a blood test that detects circulating DNA tumor DNA, may not only sound an early alert that a treatment effect is diminishing but may also may offer clues about what to do next according to a new study published Researchers say “We have shown that integrating regular liquid biopsy into our patient routine care is feasible and easily incorporated into clinical practice.” ” This technology can precisely help us understand each patient’s individual disease course and allows us to tailor care based on an understanding of their significant disease biology.”
In the study 40 patients with various forms of gastro-intestinal (GI) cancers who had previously responded to treatment that stopped were included. Liquid biopsies were done when their disease began to progress and circulating tumor DNA in the blood was analyzed for genetic mutation that might be making patients resistant to treatment. Thirty one of the 40 patients had at least one mutation, and 14 had more than 1 mutation. It was interesting that about two thirds of patients had traditional biopsies taken at the same time and the liquid biopsy picked up extra mutations that could not be seen in the tissue biopsy. Researchers said “Identifying what specific mutations are responsible for treatment resistance is very important in helping clinicians choosing what treatment path a patient should try next, whether it be another drug or prehaps radiation.”
Although liquid biopsies are not widely used outside the research setting, the researchers believe they are about to transform cancer treatment. The researchers say “We have shown this approach to be feasible across different GI cancers.” “Thew next step is to study how best to use this technology in daily practice.”
NB>I came across liquid biopsies a couple months ago while working on content for my cancer website . I will have the test information on the site within the next month as it is used to detect cancer and can do so before many other tests. However, the major problem now is that the cost can be up to $4,500.
Dr Sandra Goodman/Positive Health/Nutrition & Cancer
Sunday, June 18th, 2017Sandra Goodman PhD, Co-founder and Editor of Positive Health PH Online, trained as a Molecular Biology scientist in Agricultural Biotechnology in Canada and the USA. Sandra was born and grew up in Montreal, Canada, a highly cosmopolitan city in Quebec, subject to the political tensions of the Canadian French and English divide. In addition to focusing upon her academic studies in the arts and sciences, Sandra was also a talented pianist and athlete, particularly in gymnastics. Having qualified as a Red Cross swimming instructor and Royal Lifesaving Society lifeguard, she greatly enjoyed teaching young adults and children to swim and overcome their fear of the water.
Sandra graduated with her PhD in Molecular Biology from McGill University with her Thesis: Expression of host genes in soybean root nodules, research attempting to identify nitrogen fixation genes in a legume, with an ultimate goal of being able to transfer such genes to non-legumes and reduce the requirement for fertilizer. Dr Goodman worked for a Multi-National Corporation in the USA as a Biotechnology Scientist until the mid-1980s, eventually traveling and settling in the UK focusing upon health issues. Author of 4 books regarding the role of Nutrition in empowering optimum health, including Nutrition and Cancer: State-of-the-Art, Vitamin C – The Master Nutrient, Germanium: The Health and Life Enhancer and numerous articles, Dr Goodman was the lead author of the Consensus Document: Nutritional and LifeStyle Guidelines for People with Cancer and compiled the Cancer and Nutrition Database for the Bristol Cancer Help Centre in 1993.
The catastrophic but flawed research paper in The Lancet in the early 1990s alleging that women with breast cancer attending the Bristol Cancer Help Centre (BCHC) were more likely to die than those undergoing conventional treatment almost led to the closure of BCHC. Having authored a scholarly article Nutritional and Lifestyle Guidelines for People with Cancer, Dr Goodman was then commissioned in the early 1990s to set up a Cancer and Nutrition database which would identify the published research papers in this field.
During the compilation of this database, drawn from some 5000 peer-reviewed research papers, it was suggested by Sandra’s long-term partner Mike Howell that there was a lack of communication of this type of research both to health professionals and the serious general reader of health information. Thus was born Positive Health magazine PH Online, which has now published over 237 issues (the print magazine ceased after Issue 150); the entire archive is exclusively online at www.positivehealth.com
Dr Goodman has worked for the past 22+ years as a co-founder and Editor of Positive Health PH Online in attempting to show that there is no divide between different types of healthcare, just different approaches, i.e. Integrated Medicine. She is passionate about making available to all people, particularly those with cancer, research information and clinical expertise in the areas of Nutrition and Complementary Therapies. She has been a member of the Therapy Advisory Panel of the Penny Brohn Cancer Care, Scientific Expert Committee member of the Alliance for Natural Health and a Patron of the Avalon Complementary Medicine Trust in Wells, Somerset. Her recent (Oct 2014) Research Proposal: Cancer Patients’ Outcomes: Comparing Integrated Alternative Therapies and Chemotherapy / Radiotherapy Treatment reviews the scientific literature regarding chemotherapy toxicity.
Dr Goodman and her long-term partner Mike Howell seek individuals with the resources, structural organization and interest to continue and expand the legacy of Positive Health PH Online forward into the 21st century, adding facilities to conduct online seminars, fundraising for alternative cancer research, as well as to promote leading holistic organizations and businesses internationally. Follow her Blog and purchase Nutrition and Cancer: State-of-the-Art. Dr S Goodman may be contacted privately for Research, Lectures and Editorial services via: sandra@positivehealth.com www.positivehealth.com sandra@drsgoodman.com www.drsgoodman.com
Enjoy the Interview below:
BPA/Inflammatory Breast Cancer Connection.
Wednesday, April 12th, 2017The chemical bisphenol A (BPA) seems to aid the survival of inflammatory breast cancer cells that reveals a possible mechanism for how the disease grows according to new research in the journal Carcinogenesis. They found that BPA increases the cell signaling pathways known as mitogen-activated protein kinases (MAPK) in inflammatory breast cancer cells. Researchers said “the study is the first to show that BPA increases signaling thorough receptors that communicate with the MAPK pathway and that the presence of BPA may lead to resistance to cancer drugs targetinmg this pathweay. In our cell model, more signaling led to increased growth of the cancer cells”
Researchers started by treating Inflammatory Breast Cancer cells with six endocrine-disrupting chemicals commonly found in the everyday environment found in food, medicine and agricultural products. The found that BPA, in addition to chemicals trichloroethane (HPTE) and methoxychlor, caused an increase in signaling to epidermal growth factor receptors (EGFR), that lie on the cell surface. When cells were treated with low doses of BPA, there was nearly a doubling of EGER and signaling to the MAPK pathway also increased. This weas accompanied with a rise in indicators of cancer cell growth. They also found that BPA exposure inhibited the effectiveness of drugs that work to kill cancer cells by inhibiting EGFR signaling. Research is ongoing.
Medical Marijuana Expert/Dr David Bearman
Sunday, April 9th, 2017
Dr David Bearman, M.D. is one of the most clinically knowledgeable physicians in the U.S. in the field of medical marijuana and will appear on the Holistic Health Show on Saturday. He has spent 40 years working in substance and drug abuse treatment and prevention programs. Dr. Bearman was a pioneer in the free and community clinic movement. His career includes public health, administrative medicine, provision of primary care, pain management and cannabinology.
His almost 40 year professional experience in the drug abuse treatment and prevention field includes being the Co-Director of the Haight-Ashbury Drug Treatment Program, being a member of Governor Reagan’s Inter Agency Task Force on Drug Abuse, a member of both the Santa Barbara and the San Diego County Drug Abuse Technical Advisor Committees, and a consultant to Hoffman-LaRoche, Santa Barbara County Schools and the National PTA. He has been recognized by the Santa Barbara Medical Society with the Humanitarian Recognition Award.
Dr. Bearman is also the author of Drugs Are NOT the Devil’s Tools: How Discrimination and Greed Created a Dysfunctional Drug Policy and How It Can Be Fixed in 2 volumes. More information is available at: http://www.davidbearmanmd.com/
Enjoy the Interview:
Cancer Development/Epigenetics/ Metabolism?
Wednesday, March 29th, 2017A new study published in Briefings in Functional Genomics evaluated how epigenetics modulate human genetic programs and how it emphasizes or silences genes and concluded that if epigenetics is disrupted. it might switch on oncogenes (genes that under certain circumstances transform cells into tumor cells) or shut down tumor suppressors. Both processes will transform cells into tumor cells and cause cancer.
Experiments carried out years ago showed that chemical modification affecting the packaging of DNA can switch genes on or off. Epigenetics evolved to explain the changes caused by modification of gene expression , instead of altering the gene code itself and focuses on factors that regulate how and when certain genes are turned on and off. In contract, epigenomics relates to the analysis of global epigenetic changes across many genes. Current research shows that complementary forces of on and off switches keep each other is check. If one force overtakes, the system gets out of equibrium. and the cells either experience unlimited growth, cancer, or death. It is believed that a better understanding of these processes will lead to counter factors to prevent cancer.